欧洲五维健康量表和六维健康调查简表在中国人群中比较结果的概况性述评
Comparison Between EuroQol Five-Dimensional Questionnaire and Short-Form 6-Dimension Health Survey for the Populations in China: A Scoping Review
查看参考文献43篇
|
文摘
|
目的通过梳理和总结基于中国人群比较欧洲五维健康量表(EQ-5D)和六维健康调查简表(SF-6D)测量属性的研究,为中国人群健康相关生命质量与健康效用测量工具的选择、应用及完善提供参考。方法在中英文数据库中进行系统文献检索,筛选出在中国人群中同时使用EQ-5D和SF-6D进行测量的原创性研究,从测量属性方面进行系统性归纳总结。结果共纳入了12篇研究,包括关于疾病人群9篇研究和关于普通人群3篇研究。两类人群的研究普遍发现EQ-5D和SF-6D量表均具有较好的可行性,但两者的效用值不能互换使用。在疾病人群中EQ-5D和SF-6D量表和效用值均具有较好的结构效度包括聚合效度与知组效度,而普通人群的研究发现两者类似维度的相关性较差。疾病人群的研究发现SF-6D相对于3水平EQ-5D有更小的天花板效应与更好的灵敏性,但与5水平EQ-5D的比较却有不一致的结果,同时,普通人群的研究发现SF-6D的灵敏性优于EQ-5D。此外,在两种人群中对于信度比如重测信度以及反应性的比较证据还很缺乏。结论总结与归纳了中国人群中直接比较两者研究的特征,以及其使用的研究方法、结果与结论。尽管仅纳入了直接比较EQ-5D和SF-6D的研究,但发现的共性问题,为今后更好地比较两者提供了方向与依据。 |
|
其他语种文摘
|
Objective By review of the studies comparing the measurements properties of EuroQol fivedimensional questionnaire (EQ-5D) and short-form 6-dimension health survey (SF-6D) in Chinese populations, this study aims to provide a reference for selecting,applying,and improving the health-related quality of life and health utility measurement tools for Chinese populations. Methods We retrieved the original studies which compared the two tools from both Chinese and English databases and then summarized the findings of the included studies from the measurement properties. Results A total of 12 studies were screened out,including 9 studies about diseased populations and 3 studies about the general populations. The included studies generally demonstrated that both EQ-5D and SF-6D had good feasibility,while the utility scores generated from them cannot be used interchangeably. For the diseased populations,both EQ-5D and SF-6D and their utility scores had good construct validity,including convergent and known-groups validity,while only the utility scores had good construct validity for the general populations. For the diseased populations,SF-6D had smaller ceiling effect and better sensitivity than EQ-5D-3L,while the comparison results between SF-6D and EQ-5D-5L were inconsistent. For the general populations,SF-6D also had better sensitivity than EQ-5D. In addition,there was little comparative evidence for reliability such as test-retest reliability and responsiveness between SF-6D and SF-6D in the two populations. Conclusion This review summarized the characteristics,methods,results,and conclusions of the studies that directly compared the two tools for the populations in China. Although only the studies directly comparing EQ-5D and SF-6D are included in this review,the common findings in these studies provide a basis for better comparison between the two in the future. |
|
来源
|
中国医学科学院学报
,2023,45(4):655-665 【核心库】
|
|
DOI
|
10.3881/j.issn.1000-503X.15186
|
|
关键词
|
欧洲五维健康量表
;
六维健康调查简表
;
中国人群
;
比较
|
|
地址
|
1.
复旦大学公共卫生学院, 上海, 200032
2.
西南财经大学公共管理学院, 成都, 611130
|
|
语种
|
中文 |
|
文献类型
|
综述型 |
|
ISSN
|
1000-503X |
|
学科
|
医药、卫生 |
|
基金
|
国家自然科学基金面上项目
|
|
文献收藏号
|
CSCD:7551656
|
参考文献 共
43
共3页
|
|
1.
Sun S. Population health status in China: EQ-5D results,by age,sex and socio-economic status,from the national health services survey 2008.
Qual Life Res,2011,20(3):309-320
|
CSCD被引
15
次
|
|
|
|
|
2.
刘国恩.
中国药物经济学评价指南(2020),2020:25-27
|
CSCD被引
1
次
|
|
|
|
|
3.
Brooks R. EuroQol: the current state of play.
Health Policy,1996,37(1):53-72
|
CSCD被引
22
次
|
|
|
|
|
4.
史会梅. 近10年成本-效用分析中EQ-5D与SF-6D应用现状的文献计量研究:基于PubMed数据库.
中国卫生经济,2014,33(3):12-15
|
CSCD被引
4
次
|
|
|
|
|
5.
王晓辉. 基于EQ-5D-5L量表的兰州市居民健康相关生命质量及影响因素研究.
中国农村卫生事业管理,2021,41(6):435-440
|
CSCD被引
3
次
|
|
|
|
|
6.
Liu G G. Chinese time trade-off values for EQ-5D health states.
Value Health,2014,17(5):597-604
|
CSCD被引
51
次
|
|
|
|
|
7.
Zhuo L. Time trade-off value set for EQ-5D-3L based on a nationally representative Chinese population survey.
Value Health,2018,21(11):1330-1337
|
CSCD被引
10
次
|
|
|
|
|
8.
Luo N. Estimating an EQ-5D-5L value set for China.
Value Health,2017,20(4):662-669
|
CSCD被引
42
次
|
|
|
|
|
9.
Brazier J. Deriving a preferencebased single index from the UK SF-36 health survey.
J Clin Epidemiol,1998,51(11):1115-1128
|
CSCD被引
6
次
|
|
|
|
|
10.
Lam C L. Valuation of the SF-6D health states is feasible,acceptable,reliable,and valid in a Chinese population.
Value Health,2008,11(2):295-303
|
CSCD被引
4
次
|
|
|
|
|
11.
刘笑晗. SF系列量表演变及SF-6D多属性效用量表的介绍.
中国卫生经济,2019,38(2):8-11
|
CSCD被引
3
次
|
|
|
|
|
12.
Wu J. Valuation of SF-6Dv2 health states in China using time trade-off and discrete-choice experiment with a duration dimension.
Pharmacoeconomics,2021,39(5):521-535
|
CSCD被引
4
次
|
|
|
|
|
13.
Leung Y Y. Comparison of Euro-Qol-5D and short form-6D utility scores in multiethnic Asian patients with psoriatic arthritis: a cross-sectional study.
J Rheumatol,2013,40(6):859-865
|
CSCD被引
1
次
|
|
|
|
|
14.
Gaujoux-Viala C. Responsiveness of EQ-5D and SF-6D in patients with early arthritis: results from the ESPOIR cohort.
Ann Rheum Dis,2012,71(9):1478-1483
|
CSCD被引
1
次
|
|
|
|
|
15.
Kanters T A. Comparison of EQ-5D and SF-6D utilities in pompe disease.
Qual Life Res,2015,24(4):837-844
|
CSCD被引
1
次
|
|
|
|
|
16.
Barton G R. Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain.
Cost Eff Resour Alloc,2009,7:12
|
CSCD被引
1
次
|
|
|
|
|
17.
Lamu A N. Validity and responsiveness of EQ-5D-5L and SF-6D in patients with health complaints attributed to their amalgam fillings: a prospective cohort study of patients undergoing amalgam removal.
Health Qual Life Outcomes,2021,19(1):125
|
CSCD被引
1
次
|
|
|
|
|
18.
Mokkink L B. The COSMIN study reached international consensus on taxonomy,terminology, and definitions of measurement properties for health-related patient-reported outcomes.
J Clin Epidemiol,2010,63(7):737-745
|
CSCD被引
36
次
|
|
|
|
|
19.
王方舟. 效用量表在中国人群中的应用研究综述.
中国药物评价,2015,32(4):244-247
|
CSCD被引
8
次
|
|
|
|
|
20.
刘柳.
欧洲五维健康量表EQ-5D-3L与EQ-5D-5L的比较研究,2018
|
CSCD被引
3
次
|
|
|
|
|
了解气象卫星更多信息，请访问